NASDAQ:VRDN News 15 December 2025

Viridian Therapeutics stock jumps to a 52-week high as VRDN traders zero in on June FDA deadline

Viridian Therapeutics shares jumped 6.4% to a 52-week high Wednesday, defying a broader market decline. The move comes as investors await the FDA’s June 30 decision on veligrotug for thyroid eye disease. Viridian was valued near $3.1 billion and reported $888 million in cash as of October.

14 January 2026

Biotechnology·NASDAQ:VRDN·Pharmaceuticals

Viridian Therapeutics, Inc. (VRDN) Stock Surges on Dec. 15, 2025: Latest News, Analyst Forecasts, and 2026 Catalysts

Viridian Therapeutics, Inc. stock (Nasdaq: VRDN) is back in the spotlight on December 15, 2025, as shares push to fresh highs amid a mix of sector news, new Wall Street coverage, and a shifting competitive landscape in thyroid eye disease (TED)—the company’s core focus. As of 9:47 a.m. ET (14:47 UTC), VRDN stock traded at $33.84, up about 4.7% on the day, after touching an intraday high of $34.92. That move extends a strong multi-month run and underscores how quickly sentiment can change around late-stage biotech names when the market smells a cleaner path to commercialization. VRDN stock today: price

15 December 2025

Biotechnology·NASDAQ:VRDN·Stock Market

Robinhood stock jumps 14% as bitcoin rebounds — what to watch before HOOD earnings

7 February 2026

Robinhood shares surged 13.95% to $82.82 Friday after bitcoin rebounded above $70,000, snapping a four-day slide. The stock remains down 17% from Jan. 30. Chief Legal Officer Daniel Gallagher sold 10,000 shares earlier in the week. Robinhood reports quarterly results Tuesday after the bell.

Alphabet stock drops for a fourth straight day as AI spending jitters linger

7 February 2026

Alphabet shares fell 2.53% to $322.86 Friday, marking a fourth straight decline as investors questioned heavy AI-related spending. The Nasdaq slipped Thursday after Alphabet detailed up to $185 billion in capex, while the Dow and S&P 500 rose Friday on chipmaker gains. U.S. markets reopen Monday, with attention on Alphabet’s outlook and upcoming jobs and inflation data.

BBAI stock jumps 16% into BigBear.ai share-vote week — what to watch next

7 February 2026

BigBear.ai Holdings shares surged 15.7% Friday to $4.72 ahead of a key shareholder vote on doubling authorized shares to 1 billion. Options trading was heavy, with a put/call ratio of 0.19. The company recently announced deals in AI customs technology and a partnership with Abu Dhabi’s AD Ports Group. The special meeting is set for Feb. 18, with online voting open until late Feb. 17.

Strategy (MSTR) stock price whipsaws after $12.4 billion loss as bitcoin steadies — what to watch next week

7 February 2026

Strategy Inc shares jumped 26.1% Friday to $134.93 after plunging 17.1% the day before, following a $12.4 billion quarterly loss tied to bitcoin price swings. The company held 713,502 bitcoins as of Feb. 1 at a cost of $54.26 billion. Bitcoin hovered near $69,000 Saturday. Strategy set up a $2.25 billion reserve to cover dividends and interest.

NASDAQ:VRDN News 15 December 2025 - 14 January 2026

Viridian Therapeutics stock jumps to a 52-week high as VRDN traders zero in on June FDA deadline

Viridian Therapeutics, Inc. (VRDN) Stock Surges on Dec. 15, 2025: Latest News, Analyst Forecasts, and 2026 Catalysts

Stock Market Today

Robinhood stock jumps 14% as bitcoin rebounds — what to watch before HOOD earnings

Alphabet stock drops for a fourth straight day as AI spending jitters linger

BBAI stock jumps 16% into BigBear.ai share-vote week — what to watch next

Strategy (MSTR) stock price whipsaws after $12.4 billion loss as bitcoin steadies — what to watch next week